S Bregenholt - Concepedia

Author

S Bregenholt

University of Copenhagen

Also Known As

Bregenholt, S., S BREGENHOLT, S Bregenholt, S. BREGENHOLT, S. Bregenholt, SOREN BREGENHOLT, SØOREN BREGENHOLT

Publications

434

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Novo Nordisk (Denmark)Universität Ulm La Jolla Institute for Immunology

About

S Bregenholt is an author at University of Copenhagen specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	153
2	Allergy	2	2	41
3	Health Sciences	1	1	36
4	Biochemistry	1	1	41
5	Biomolecular Engineering	1	1	35

S Bregenholt

Publications

393

Citations

H-Index

Page 1

	Year	Citations
MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis Søren Skov, S Bregenholt, Mogens H. Claësson The Journal of Immunology	1997	77
Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions S Bregenholt, Søren Skov, M H Claësson The Journal of Immunology	1996	45
Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes Jacob Petersen, S Bregenholt, V APOSTOLOPOLOUS, Clinical & Experimental Immunology Class IiAutoimmune DiseaseBiochemistryInsulin ManagementPathogenesis	2003	41
The Cholera Toxin B Subunit is a Mucosal Adjuvant for Oral Tolerance Induction in Type 1 Diabetes S Bregenholt, M. Wang, T. Wolfe, Scandinavian Journal of Immunology ImmunologyImmunotherapyMucosal AdjuvantInsulin SignalingDrug Resistance	2003	36
GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical development Lisbeth B. Knudsen, Christina Bjenning, S Bregenholt, Drugs of the Future Glp-1 DerivativesDiabetes ManagementMedicineDrug DiscoveryDiabetes	2001	35
The CC‐chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells Niels Ødum, S Bregenholt, Kirsten Eriksen, Tissue Antigens	1999	34
<i>In vitro</i>activated CD4+ T cells from interferon-gamma (IFN-γ)-deficient mice induce intestinal inflammation in immunodeficient hosts S Bregenholt, Jens Brimnes, Mogens Holst Nissen, Clinical & Experimental Immunology	1999	26
C1-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro. Mogens Holst Nissen, S Bregenholt, J. A. Nording, International Immunology Lymphocyte DevelopmentImmunologyImmunologic MechanismCell ProliferationImmune System	1998	22
Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD) S Bregenholt, Mogens H. Claësson Clinical & Experimental Immunology	1998	21
An improved method for the detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells. Matthias Regner, M H Claësson, S Bregenholt PubMed Improved MethodMhc ClassT-regulatory CellHla ImmunogeneticsImmunology	1996	19

Page 1